Both in Pharmaceuticals
Mannkind vs Aktis Oncology
Over the past year MNKD returned −42.9% and AKTS returned −12.1%; their daily moves had a correlation of 0.23.
MNKD −42.9% AKTS −12.1%Growth of $1, one year, split-adjusted
| Metric | MNKD | AKTS |
|---|---|---|
| Price | $3.34 | $19.69 |
| Market cap | $1.07B | $1.10B |
| Today | −0.30% | +1.76% |
| 1 month | −15.4% | −23.6% |
| 6 months | +40.9% | +19.0% |
| Year to date | −41.1% | — |
| 1 year | −39.6% | — |
| Revenue growth (YoY) | +42.9% | — |
| Gross margin | 73.0% | 100.0% |
| Net margin | −17.4% | −713.5% |
| P/E (TTM) | — | — |
| Price / sales | 2.7× | — |
| Net cash | -$373.9M | $517.3M |
| Dividend yield | — | — |
| Volatility (60d) | 49.6% | 52.5% |
| Short % of float | 10.5% | 14.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).